期刊文献+

支气管扩张合并感染患者纤维支气管镜下支气管分泌物病原菌培养及耐药性分析 被引量:52

Pathogenic bacteria recovered from bronchial secretions by bronchofiberscope and their antibiotic resistance profile in bronchiectasis patients complicated with infection
暂未订购
导出
摘要 目的探讨支气管扩张合并感染患者纤维支气管镜下支气管分泌物培养病原菌分布及耐药情况,为合理选择抗菌药物治疗提供参考。方法选取2013年6月-2015年12月华中科技大学同济医学院附属梨园医院呼吸内科住院的支气管扩张合并感染患者97例,收集纤维支气管镜下支气管分泌物标本进行病原菌培养及药敏试验。结果 97例患者支气管分泌物分离病原菌53株(54.6%),其中革兰阴性杆菌49株(占92.4%),以铜绿假单胞菌为主,其次为鲍曼不动杆菌、肺炎克雷伯菌;革兰阳性菌3株(占5.7%),为金黄色葡萄球菌2株和肺炎链球菌1株;真菌1株(1.9%),为白念珠菌。药敏试验结果显示,铜绿假单胞菌对妥布霉素、阿米卡星、头孢吡肟、氨曲南敏感率较高(均>70%),对左氧氟沙星耐药率最高(为100%);鲍曼不动杆菌对妥布霉素、阿米卡星敏感率较高(均为85.7%),其次对亚胺培南(42.9%);肺炎克雷伯菌对头孢噻肟、庆大霉素、环丙沙星、左氧氟沙星耐药率较高(均>50%)。结论支气管扩张合并感染患者纤维支气管镜下分泌物培养病原菌以革兰阴性杆菌为主,其药敏试验结果显示对妥布霉素、阿米卡星敏感率较高,对环丙沙星、左氧氟沙星耐药率较高。研究对治疗支气管扩张合并感染患者具有重要指导意义。 Objective To analyze the antibiotic resistance of pathogenic bacteria recovered from bronchial secretions by bronchofiberscope in bronchiectasis patients complicated with infection for improving antibacterial therapy. Methods A total of 97 bronchiectasis patients complicated with infection treated in Liyuan Hospital during the period from June 2013 to December 2015 were included in this analysis. The pathogens were recovered from bronchial secretions by bronchofiberscope and subjected to antimicrobial susceptibility testing by Kirby-Bauer disc method. The data were analyzed with WHONET 5.5 software. Results Pathogenic organisms were isolated from 53 (54.6%) of the 97 patients, including 49 (92.4%) strains of gram negative bacilli, mainly Pseudomonas aeruginosa, followed by Acinetobacter baumannii, Klebsiella pneumoniae, 3 (5.7%) strains of gram positive cocci, specifically 2 strains of S. aureus and 1 strain of S. pneumoniae, and 1 (1.9%) strain of Candida albicans. Antimicrobial susceptibility testing showed that most P. aeruginosa isolates (〉71.8%) were susceptible to tobramvcin, amikacin.cefepime, and aztreonam, but 100% resistant to levofloxacin. More A. baumannii isolates were susceptible to tobramycin and amikacin (both 85.7%), followed by imipenem (〉42.9%). More than half (〉 50%) of the K. pneumoniae isolates were resistant to cefotaxime, gentamycin, ciprofloxacin, and levofloxacin.Conclusions Gram negative bacilli are dominant in the pathogenic organisms recovered from bronchial secretions in bronchiectasis patients complicated with infection. Most of the pathogens are relatively susceptible to tobramycin and amikacin, but resistant to ciprofloxacin and levofloxacin.
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2017年第2期140-143,共4页 Chinese Journal of Infection and Chemotherapy
关键词 纤维支气管镜 支气管扩张 支气管分泌物 病原菌 bronchofiberscope bronchiectasis bronchial secretion pathogenic bacteria
  • 相关文献

参考文献10

二级参考文献112

  • 1Ozalp O,Inal-Ince D,Calik E,et al.Extrapulmonary featuresof bronchiectasis:muscle function,exercise capacity,fatigue,and health status[J].Multidiscip respire Med,2012,7(1):3-9.
  • 2Drain M,ElbomJS.Assessment and investigation of adult withbronchiectasis[J].Eur Respir Mon,2011:5232-5243.
  • 3Woodhead M,Blasi F,Ewig S,et al.Guidelines for the man-agement of adult lower respiratory tract infection-full version[J].Clin Microbiol infect,2011,17(6):1-59.
  • 4Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 6Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 7Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 8Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 9van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 10Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.

共引文献1403

同被引文献406

引证文献52

二级引证文献382

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部